Published in J Neurotrauma on April 20, 2010
Autologous olfactory mucosal cell transplants in clinical spinal cord injury: a randomized double-blinded trial in a canine translational model. Brain (2012) 1.87
Translational stem cell therapy for amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 1.32
Advances in stem cell therapy for spinal cord injury. J Clin Invest (2012) 1.24
Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One (2012) 1.14
An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev (2012) 1.11
Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int Arch Med (2010) 1.09
Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury. J Neurosci (2014) 1.08
Design of three-dimensional engineered protein hydrogels for tailored control of neurite growth. Acta Biomater (2012) 1.05
Stem cell therapy and curcumin synergistically enhance recovery from spinal cord injury. PLoS One (2014) 1.02
Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics (2011) 1.01
A systematic review of the effects of pharmacological agents on walking function in people with spinal cord injury. J Neurotrauma (2012) 0.98
Injury to the spinal cord niche alters the engraftment dynamics of human neural stem cells. Stem Cell Reports (2014) 0.98
Safety of human neural stem cell transplantation in chronic spinal cord injury. Stem Cells Transl Med (2013) 0.97
Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats. PLoS One (2013) 0.95
Neurotrophic factors in combinatorial approaches for spinal cord regeneration. Cell Tissue Res (2012) 0.93
Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model. Exp Neurol (2013) 0.93
Wnts are expressed in the spinal cord of adult mice and are differentially induced after injury. J Neurotrauma (2014) 0.92
Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials. World J Stem Cells (2014) 0.90
Transplantation of D15A-expressing glial-restricted-precursor-derived astrocytes improves anatomical and locomotor recovery after spinal cord injury. Int J Biol Sci (2012) 0.89
The role of the serotonergic system in locomotor recovery after spinal cord injury. Front Neural Circuits (2015) 0.87
Functional consequences of ethidium bromide demyelination of the mouse ventral spinal cord. Exp Neurol (2013) 0.87
Regenerative medicine for the treatment of spinal cord injury: more than just promises? J Cell Mol Med (2012) 0.87
Interplay between human microglia and neural stem/progenitor cells in an allogeneic co-culture model. J Cell Mol Med (2013) 0.87
Biomaterial-based interventions for neuronal regeneration and functional recovery in rodent model of spinal cord injury: a systematic review. J Spinal Cord Med (2013) 0.86
Gene expression changes in the injured spinal cord following transplantation of mesenchymal stem cells or olfactory ensheathing cells. PLoS One (2013) 0.86
Transplantation of neural stem cells clonally derived from embryonic stem cells promotes recovery after murine spinal cord injury. Stem Cells Dev (2015) 0.85
Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury. Stem Cells Transl Med (2016) 0.85
Permissive Schwann cell graft/spinal cord interfaces for axon regeneration. Cell Transplant (2013) 0.85
Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury. J Control Release (2015) 0.85
Genome-wide expression profile of the response to spinal cord injury in Xenopus laevis reveals extensive differences between regenerative and non-regenerative stages. Neural Dev (2014) 0.85
Intrathecal Transplantation of Autologous Adherent Bone Marrow Cells Induces Functional Neurological Recovery in a Canine Model of Spinal Cord Injury. Cell Transplant (2014) 0.84
Injured mice at the gym: review, results and considerations for combining chondroitinase and locomotor exercise to enhance recovery after spinal cord injury. Brain Res Bull (2010) 0.84
Chondroitinase ABC plus bone marrow mesenchymal stem cells for repair of spinal cord injury. Neural Regen Res (2013) 0.84
Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration. Stem Cells Int (2015) 0.84
Regeneration of Xenopus laevis spinal cord requires Sox2/3 expressing cells. Dev Biol (2015) 0.84
Vascular disruption and the role of angiogenic proteins after spinal cord injury. Transl Stroke Res (2011) 0.84
The ependymal region of the adult human spinal cord differs from other species and shows ependymoma-like features. Brain (2015) 0.83
Myelin damage and repair in pathologic CNS: challenges and prospects. Front Mol Neurosci (2015) 0.83
Schwann cell coculture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice. Cell Transplant (2010) 0.82
Transplantation of Defined Populations of Differentiated Human Neural Stem Cell Progeny. Sci Rep (2016) 0.82
Evaluation of spinal cord injury animal models. Neural Regen Res (2014) 0.82
Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update. Biomed Res Int (2015) 0.82
Role of endogenous Schwann cells in tissue repair after spinal cord injury. Neural Regen Res (2013) 0.81
Sustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injury. J Control Release (2015) 0.81
Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis. Eur Spine J (2014) 0.80
The assessment of adeno-associated vectors as potential intrinsic treatments for brainstem axon regeneration. J Gene Med (2012) 0.80
Biomedical and clinical promises of human pluripotent stem cells for neurological disorders. Biomed Res Int (2013) 0.80
Improvement of Contused Spinal Cord in Rats by Cholinergic-like Neuron Therapy. Iran Red Crescent Med J (2013) 0.80
A 3D in vitro model reveals differences in the astrocyte response elicited by potential stem cell therapies for CNS injury. Regen Med (2013) 0.80
Combination therapy of stem cell derived neural progenitors and drug delivery of anti-inhibitory molecules for spinal cord injury. Acta Biomater (2015) 0.79
Molecular imaging in stem cell therapy for spinal cord injury. Biomed Res Int (2014) 0.79
Bridging defects in chronic spinal cord injury using peripheral nerve grafts combined with a chitosan-laminin scaffold and enhancing regeneration through them by co-transplantation with bone-marrow-derived mesenchymal stem cells: case series of 14 patients. J Spinal Cord Med (2013) 0.79
Synaptically-competent neurons derived from canine embryonic stem cells by lineage selection with EGF and Noggin. PLoS One (2011) 0.79
Efficacy of Schwann cell transplantation for spinal cord repair is improved with combinatorial strategies. J Physiol (2016) 0.79
Spinal cord injury - there is not just one way of treating it. F1000Prime Rep (2014) 0.79
Bridging the lesion-engineering a permissive substrate for nerve regeneration. Regen Biomater (2015) 0.79
The State of Play with iPSCs and Spinal Cord Injury Models. J Clin Med (2015) 0.79
Characterization of Neurogenic Potential of Dental Pulp Stem Cells Cultured in Xeno/Serum-Free Condition: In Vitro and In Vivo Assessment. Stem Cells Int (2016) 0.78
Transplantation of adult monkey neural stem cells into a contusion spinal cord injury model in rhesus macaque monkeys. Cell J (2014) 0.78
Glial restricted precursors maintain their permissive properties after long-term expansion but not following exposure to pro-inflammatory factors. Brain Res (2015) 0.78
Meta analysis of olfactory ensheathing cell transplantation promoting functional recovery of motor nerves in rats with complete spinal cord transection. Neural Regen Res (2014) 0.78
The reactions and role of NG2 glia in spinal cord injury. Brain Res (2015) 0.78
Harnessing the power of cell transplantation to target respiratory dysfunction following spinal cord injury. Exp Neurol (2016) 0.78
Translational spinal cord injury research: preclinical guidelines and challenges. Handb Clin Neurol (2012) 0.78
Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation. Biotechnol Bioeng (2016) 0.77
Stem cell therapy for central nerve system injuries: glial cells hold the key. Neural Regen Res (2014) 0.77
Neural precursor cell transplantation enhances functional recovery and reduces astrogliosis in bilateral compressive/contusive cervical spinal cord injury. Stem Cells Transl Med (2014) 0.77
Current stem cell treatments for spinal cord injury. Indian J Orthop (2012) 0.77
Advances in regenerative therapies for spinal cord injury: a biomaterials approach. Neural Regen Res (2015) 0.77
Engrafted Neural Stem/Progenitor Cells Promote Functional Recovery through Synapse Reorganization with Spared Host Neurons after Spinal Cord Injury. Stem Cell Reports (2015) 0.77
The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges. J Clin Med (2014) 0.76
Stem cell therapy in spinal cord injury: Hollow promise or promising science? J Craniovertebr Junction Spine (2016) 0.76
Fibroblasts isolated from human middle turbinate mucosa cause neural progenitor cells to differentiate into glial lineage cells. PLoS One (2013) 0.76
Organotypic spinal cord slice culture to study neural stem/progenitor cell microenvironment in the injured spinal cord. Exp Neurobiol (2010) 0.76
Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes. J Neurotrauma (2015) 0.76
Olfactory Ensheathing Cell Transplantation in Experimental Spinal Cord Injury: Effect size and Reporting Bias of 62 Experimental Treatments: A Systematic Review and Meta-Analysis. PLoS Biol (2016) 0.76
Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials? Exp Neurol (2016) 0.76
Bone Marrow Stromal Cell Intraspinal Transplants Fail to Improve Motor Outcomes in a Severe Model of Spinal Cord Injury. J Neurotrauma (2015) 0.76
Spinal cord injury: a review of the most-cited publications. Eur Spine J (2016) 0.76
Neural stem cells respond to stress hormones: distinguishing beneficial from detrimental stress. Front Physiol (2015) 0.76
Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury. Stem Cells Int (2016) 0.76
Generation of magnetized olfactory ensheathing cells for regenerative studies in the central and peripheral nervous tissue. Int J Mol Sci (2013) 0.76
Cell transplantation therapy for spinal cord injury. Nat Neurosci (2017) 0.75
An efficient system for selection and culture of Schwann cells from adult rat peripheral nerves. Cytotechnology (2015) 0.75
Antioxidant and Anti-Senescence Effect of Metformin on Mouse Olfactory Ensheathing Cells (mOECs) May Be Associated with Increased Brain-Derived Neurotrophic Factor Levels-An Ex Vivo Study. Int J Mol Sci (2017) 0.75
Differential Histopathological and Behavioral Outcomes Eight Weeks after Rat Spinal Cord Injury by Contusion, Dislocation, and Distraction Mechanisms. J Neurotrauma (2016) 0.75
Factors affecting directional migration of bone marrow mesenchymal stem cells to the injured spinal cord. Neural Regen Res (2014) 0.75
Human olfactory mesenchymal stromal cell transplants promote remyelination and earlier improvement in gait co-ordination after spinal cord injury. Glia (2017) 0.75
Alginic acid sodium hydrogel co-transplantation with Schwann cells for rat spinal cord repair. Arch Med Sci (2012) 0.75
Minimally manipulated autologous adherent bone marrow cells (ABMCs): a promising cell therapy of spinal cord injury. Neural Regen Res (2015) 0.75
Protection and Repair After Spinal Cord Injury: Accomplishments and Future Directions. Top Spinal Cord Inj Rehabil (2015) 0.75
Creation of an intramedullary cavity by hemorrhagic necrosis removal 24 h after spinal cord contusion in rats for eventual intralesional implantation of restorative materials. PLoS One (2017) 0.75
Induced Pluripotent Stem Cells for Traumatic Spinal Cord Injury. Front Cell Dev Biol (2017) 0.75
Transplantation of neural progenitor cells in chronic spinal cord injury. Neuroscience (2016) 0.75
Electrical stimulation of transplanted motoneurons improves motor unit formation. J Neurophysiol (2014) 0.75
Increased Brain Sensorimotor Network Activation after Incomplete Spinal Cord Injury. J Neurotrauma (2016) 0.75
Cellular Therapies in Trauma and Critical Care Medicine: Forging New Frontiers. Shock (2015) 0.75
Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury. Int J Mol Sci (2016) 0.75
Effects of microtubule-associated protein tau expression on neural stem cell migration after spinal cord injury. Neural Regen Res (2016) 0.75
Successful transplantation of motoneurons into the peripheral nerve depends on the number of transplanted cells. Nagoya J Med Sci (2015) 0.75
Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci (2005) 5.66
Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med (1999) 4.44
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A (2002) 4.03
Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci (2005) 3.74
cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med (2004) 3.65
Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A (2005) 3.56
Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science (1997) 3.53
Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A (2002) 3.35
Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair (2009) 3.15
Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol (2003) 3.09
Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport (2000) 2.49
Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant (2007) 2.47
Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron (2000) 2.46
Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci (2005) 2.30
Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci (2004) 2.14
Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci (2006) 2.13
Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol (2001) 2.12
Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res (2002) 2.06
Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain (2002) 2.04
Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci (2002) 1.98
Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci (1998) 1.98
OEG implantation and step training enhance hindlimb-stepping ability in adult spinal transected rats. Brain (2007) 1.94
Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res (2005) 1.88
Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain (2000) 1.85
Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor. Exp Neurol (2004) 1.82
In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J (2005) 1.80
Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord. Nat Biotechnol (2000) 1.76
BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol (2005) 1.75
Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci (2005) 1.75
Neurotrophin-3 gradients established by lentiviral gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal cord. J Neurosci (2006) 1.73
Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord. Exp Neurol (2005) 1.73
Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol (1995) 1.70
A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol (1995) 1.70
Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol (2004) 1.66
Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil Neural Repair (2006) 1.66
Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res (2004) 1.66
Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J Neurosci (2007) 1.63
Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Exp Neurol (2002) 1.53
Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells (2007) 1.53
Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells. Transplantation (2008) 1.51
Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res (2005) 1.51
Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci U S A (2006) 1.50
Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma (2006) 1.50
Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury. FASEB J (2003) 1.49
Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol (2004) 1.47
Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci (2001) 1.44
Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J Neurosci (1998) 1.42
Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury. Stem Cells (2006) 1.38
Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord. J Neurocytol (1997) 1.37
Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine (Phila Pa 1976) (2004) 1.37
Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration. Exp Neurol (2004) 1.36
Axon regeneration through scars and into sites of chronic spinal cord injury. Exp Neurol (2006) 1.36
Adult neural progenitor cell grafts survive after acute spinal cord injury and integrate along axonal pathways. Eur J Neurosci (2003) 1.34
Regrowth of axons into the distal spinal cord through a Schwann-cell-seeded mini-channel implanted into hemisected adult rat spinal cord. Eur J Neurosci (1999) 1.30
Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med (2006) 1.29
Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry. J Neurosci (2005) 1.29
Transplanted adult spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury. Neuroscience (2008) 1.28
Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol (2006) 1.28
Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. Exp Neurol (2006) 1.27
Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. J Neurosci Res (2003) 1.26
The ability of human Schwann cell grafts to promote regeneration in the transected nude rat spinal cord. Exp Neurol (1997) 1.25
Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur J Neurosci (2005) 1.24
Translational research in spinal cord injury: a survey of opinion from the SCI community. J Neurotrauma (2010) 1.23
Templated agarose scaffolds support linear axonal regeneration. Tissue Eng (2006) 1.21
Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury. J Neurotrauma (2007) 1.21
Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys. Cytotherapy (2006) 1.21
Transplantation of Schwann cells and olfactory ensheathing glia after spinal cord injury: does pretreatment with methylprednisolone and interleukin-10 enhance recovery? J Neurotrauma (2004) 1.21
Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner. Neurosci Lett (2007) 1.18
Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats. Acta Neurobiol Exp (Wars) (2007) 1.17
Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival. Glia (2006) 1.17
Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. Spine J (2004) 1.17
Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur J Neurosci (2001) 1.17
The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model. Cytotherapy (2008) 1.17
Embryonic radial glia bridge spinal cord lesions and promote functional recovery following spinal cord injury. Exp Neurol (2005) 1.16
Transplantation of olfactory ensheathing cells or Schwann cells restores rapid and secure conduction across the transected spinal cord. Brain Res (2000) 1.16
Glial cell line-derived neurotrophic factor-enriched bridging transplants promote propriospinal axonal regeneration and enhance myelination after spinal cord injury. Exp Neurol (2003) 1.15
Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology (2003) 1.15
Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord. Eur J Neurosci (1998) 1.14
Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. J Neurosci Res (2007) 1.14
Survival, integration, and axon growth support of glia transplanted into the chronically contused spinal cord. Cell Transplant (2005) 1.14
Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration? Neurosci Lett (2006) 1.14
Transduced Schwann cells promote axon growth and myelination after spinal cord injury. Exp Neurol (2007) 1.13
Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats. Brain Res (2001) 1.13
PNS-CNS transitional zone of the first cranial nerve. J Comp Neurol (1991) 1.11
Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury. Brain (2007) 1.11
Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regen Med (2006) 1.09
Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury. J Neurosci Res (2006) 1.08
Transplantation of rat Schwann cells grown in tissue culture into the mouse spinal cord. J Neurol Sci (1981) 1.08
Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. Exp Hematol (2006) 1.07
Schwann cell transplantation improves reticulospinal axon growth and forelimb strength after severe cervical spinal cord contusion. Cell Transplant (2007) 1.07
Transplantation of autologous Schwann cells for the repair of segmental peripheral nerve defects. Neurosurg Focus (2009) 1.07
Neural precursor cells can be delivered into the injured cervical spinal cord by intrathecal injection at the lumbar cord. Brain Res (2005) 1.06
Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. Neurosci Lett (2008) 1.06
Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1. J Comp Neurol (1999) 1.05
Bone marrow stromal cells can achieve cure of chronic paraplegic rats: functional and morphological outcome one year after transplantation. Neurosci Lett (2006) 1.05
Functional recovery in chronic paraplegia after bone marrow stromal cells transplantation. Neuroreport (2004) 1.05
Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats. Neurochem Res (2007) 1.05
Inhibitory proteoglycan immunoreactivity is higher at the caudal than the rostral Schwann cell graft-transected spinal cord interface. Mol Cell Neurosci (2001) 1.04
A new classification of thoracolumbar injuries: the importance of injury morphology, the integrity of the posterior ligamentous complex, and neurologic status. Spine (Phila Pa 1976) (2005) 3.68
Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J Neurosci (2008) 2.79
The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma (2004) 2.48
Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors. Int J Radiat Oncol Biol Phys (2012) 2.45
Surgical management of tethered cord syndrome in adults: indications, techniques, and long-term outcomes in 60 patients. J Neurosurg Spine (2006) 2.43
Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus (2008) 2.37
Reliability of the spinal instability neoplastic scale among radiologists: an assessment of instability secondary to spinal metastases. AJR Am J Roentgenol (2014) 2.28
Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci (2006) 2.13
Causal assessment of occupational lifting and low back pain: results of a systematic review. Spine J (2010) 2.09
Toward the Development of a Universal Outcome Instrument for Spine Trauma: A Systematic Review and Content Comparison of Outcome Measures Used in Spine Trauma Research Using the ICF as Reference. Spine (Phila Pa 1976) (2016) 2.05
Comparative effectiveness of surgical versus nonoperative management of unilateral, nondisplaced, subaxial cervical spine facet fractures without evidence of spinal cord injury: clinical article. J Neurosurg Spine (2014) 1.97
Proposal of a modified, treatment-oriented classification of odontoid fractures. Spine J (2005) 1.94
A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976) (2010) 1.91
Clinical practice. Cervical radiculopathy. N Engl J Med (2005) 1.91
Intraoperative adverse events and related postoperative complications in spine surgery: implications for enhancing patient safety founded on evidence-based protocols. Spine (Phila Pa 1976) (2006) 1.89
Spinal cord injury: time to move? J Neurosci (2007) 1.87
Injury of the posterior ligamentous complex of the thoracolumbar spine: a prospective evaluation of the diagnostic accuracy of magnetic resonance imaging. Spine (Phila Pa 1976) (2009) 1.86
Causal assessment of occupational bending or twisting and low back pain: results of a systematic review. Spine J (2009) 1.86
The thoracolumbar injury severity score: a proposed treatment algorithm. J Spinal Disord Tech (2005) 1.82
Acute cervical traumatic spinal cord injury: MR imaging findings correlated with neurologic outcome--prospective study with 100 consecutive patients. Radiology (2007) 1.81
Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain (2003) 1.81
The surgical approach to subaxial cervical spine injuries: an evidence-based algorithm based on the SLIC classification system. Spine (Phila Pa 1976) (2007) 1.78
Pharmacological approaches to repair the injured spinal cord. J Neurotrauma (2006) 1.77
Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction. J Neurosci (2007) 1.74
Incidence and prevalence of spinal cord injury in Canada: a national perspective. Neuroepidemiology (2012) 1.74
Surgical management of cervical degenerative disease: the evidence related to indications, impact, and outcome. J Neurosurg Spine (2009) 1.72
Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol (2011) 1.69
Fast, cheap and out of control: a zero curation model for ontology development. Pac Symp Biocomput (2006) 1.67
Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J Neurosci (2007) 1.63
Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. J Neurosci (2006) 1.63
Autonomic dysreflexia in acute spinal cord injury: an under-recognized clinical entity. J Neurotrauma (2003) 1.63
Hypothermia for spinal cord injury. Spine J (2008) 1.61
Radiation-induced vertebral compression fracture following spine stereotactic radiosurgery: clinicopathological correlation. J Neurosurg Spine (2013) 1.61
Os odontoideum: etiology and surgical management. Neurosurgery (2010) 1.59
Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci (2010) 1.59
Pathophysiology of cervical myelopathy. Spine J (2006) 1.56
Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus (2008) 1.56
Timing of decompressive surgery of spinal cord after traumatic spinal cord injury: an evidence-based examination of pre-clinical and clinical studies. J Neurotrauma (2010) 1.54
A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma (2010) 1.54
Diagnosis and management of metastatic spine disease. A review. J Neurosurg Spine (2010) 1.52
Causal assessment of awkward occupational postures and low back pain: results of a systematic review. Spine J (2009) 1.51
Cardiovascular complications after acute spinal cord injury: pathophysiology, diagnosis, and management. Neurosurg Focus (2008) 1.51
Multimodality intraoperative monitoring during complex lumbosacral procedures: indications, techniques, and long-term follow-up review of 61 consecutive cases. J Neurosurg Spine (2004) 1.50
Effectiveness of titanium mesh cylindrical cages in anterior column reconstruction after thoracic and lumbar vertebral body resection. Spine (Phila Pa 1976) (2003) 1.49
Radiographic measurement parameters in thoracolumbar fractures: a systematic review and consensus statement of the spine trauma study group. Spine (Phila Pa 1976) (2006) 1.45
Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma (2002) 1.44
Predictors of outcome in patients with degenerative cervical spondylotic myelopathy undergoing surgical treatment: results of a systematic review. Eur Spine J (2013) 1.43
Spinal cord injury: a systematic review of current treatment options. Clin Orthop Relat Res (2011) 1.41
Pitfalls in the publication of scientific literature: a road map to manage conflict of interest and other ethical challenges. J Neurosurg (2010) 1.40
Ankylosing spondylitis and spinal cord injury: origin, incidence, management, and avoidance. Neurosurg Focus (2008) 1.40
Two TTX-resistant Na+ currents in mouse colonic dorsal root ganglia neurons and their role in colitis-induced hyperexcitability. Am J Physiol Gastrointest Liver Physiol (2004) 1.39
Admission and acute complication rate for outpatient lumbar microdiscectomy. Can J Neurol Sci (2010) 1.38
Idiopathic spinal cord herniation: report of eight cases and review of the literature. Spine (Phila Pa 1976) (2002) 1.37
Sensorimotor cortical plasticity during recovery following spinal cord injury: a longitudinal fMRI study. Neurorehabil Neural Repair (2007) 1.35
Postoperative wound infections of the spine. Neurosurg Focus (2003) 1.35
A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. J Neurotrauma (2011) 1.34
Update on the treatment of spinal cord injury. Prog Brain Res (2007) 1.29
Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. J Neurosci (2004) 1.28
Degenerative Cervical Myelopathy: Epidemiology, Genetics, and Pathogenesis. Spine (Phila Pa 1976) (2015) 1.27
Surgeon perceptions and reported complications in spine surgery. Spine (Phila Pa 1976) (2010) 1.26
Intraoperative multimodality monitoring in adult spinal deformity: analysis of a prospective series of one hundred two cases with independent evaluation. Spine (Phila Pa 1976) (2009) 1.25
Cervical spondylotic myelopathy: the clinical phenomenon and the current pathobiology of an increasingly prevalent and devastating disorder. Neuroscientist (2012) 1.24
Functional and clinical outcomes following surgical treatment in patients with cervical spondylotic myelopathy: a prospective study of 81 cases. J Neurosurg Spine (2011) 1.23
Surgical decision making for unstable thoracolumbar spine injuries: results of a consensus panel review by the Spine Trauma Study Group. J Spinal Disord Tech (2006) 1.21
Do no harm: the balance of "beneficence" and "non-maleficence". Spine (Phila Pa 1976) (2010) 1.21
Agreement between orthopedic surgeons and neurosurgeons regarding a new algorithm for the treatment of thoracolumbar injuries: a multicenter reliability study. J Spinal Disord Tech (2006) 1.21
Real-time continuous intraoperative electromyographic and somatosensory evoked potential recordings in spinal surgery: correlation of clinical and electrophysiologic findings in a prospective, consecutive series of 213 cases. Spine (Phila Pa 1976) (2004) 1.20
Notochordal cells protect nucleus pulposus cells from degradation and apoptosis: implications for the mechanisms of intervertebral disc degeneration. Arthritis Res Ther (2011) 1.19
A graded forceps crush spinal cord injury model in mice. J Neurotrauma (2008) 1.19
Instability and impending instability of the thoracolumbar spine in patients with spinal metastases: a systematic review. Int J Oncol (2011) 1.19
Pathophysiology and natural history of cervical spondylotic myelopathy. Spine (Phila Pa 1976) (2013) 1.17
A clinical prediction model to determine outcomes in patients with cervical spondylotic myelopathy undergoing surgical treatment: data from the prospective, multi-center AOSpine North America study. J Bone Joint Surg Am (2013) 1.17
Industry and evidence-based medicine: Believable or conflicted? A systematic review of the surgical literature. Can J Surg (2011) 1.16
The epidemiology of traumatic spinal cord injury in British Columbia, Canada. Spine (Phila Pa 1976) (2012) 1.15
Causal assessment of occupational sitting and low back pain: results of a systematic review. Spine J (2010) 1.14
Predictive value of intraoperative neurophysiological monitoring during cervical spine surgery: a prospective analysis of 1055 consecutive patients. J Neurosurg Spine (2008) 1.14
A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J Neurotrauma (2010) 1.13
A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J Neurotrauma (2013) 1.13
Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases. Lancet Oncol (2013) 1.12
Is there a role for hyperoxia in the management of severe traumatic brain injury? J Neurosurg (2007) 1.12
Motor and sensory assessment of patients in clinical trials for pharmacological therapy of acute spinal cord injury: psychometric properties of the ASIA Standards. J Neurotrauma (2008) 1.12
Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol (2013) 1.12
The use of C1 lateral mass screws in complex cervical spine surgery: indications, techniques, and outcome in a prospective consecutive series of 25 cases. J Spinal Disord Tech (2007) 1.12
Development of the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP): reviewing measurement specific to the upper limb in tetraplegia. J Neurosurg Spine (2012) 1.11
An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev (2012) 1.11
Morbidity and mortality of major adult spinal surgery. A prospective cohort analysis of 942 consecutive patients. Spine J (2011) 1.10
Causal assessment of occupational standing or walking and low back pain: results of a systematic review. Spine J (2010) 1.10
A systematic review of directly applied biologic therapies for acute spinal cord injury. J Neurotrauma (2010) 1.10
Chronic low back pain: a heterogeneous condition with challenges for an evidence-based approach. Spine (Phila Pa 1976) (2011) 1.10
The impact of specialized centers of care for spinal cord injury on length of stay, complications, and mortality: a systematic review of the literature. J Neurotrauma (2011) 1.09